Tenet Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tenet Healthcare (THC).

Price Target Range — 9 Quarters

Analyst Consensus — 20 Analysts

18Buy

2Hold

Consensus RatingOverweight# Analysts20Avg. Consensus PT$262Upside to Avg. PT-4.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 3, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$290→$305
Nov 3, 2026	Keybanc	Matthew Gillmor	PT Raise	Overweight	$270→$300
Nov 2, 2026	Leerink Partners	Whit Mayo	PT Raise	Outperform	$309→$342
Nov 2, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$283→$304
Nov 2, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$281→$321
Oct 30, 2026	Guggenheim	Jason Cassorla	PT Cut	Buy	$307→$306
Oct 16, 2026	Guggenheim	Jason Cassorla	PT Raise	Buy	$283→$307
Sep 23, 2026	BMO Capital	Sean Dodge	Initiate	Market Perform	$265
Sep 18, 2026	Leerink Partners	Whit Mayo	Maintained	Outperform	$309
Aug 3, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$231→$281
Jul 28, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$270→$290
Jul 28, 2026	Baird	Michael Ha	PT Raise	Neutral	$210→$280
Jul 28, 2026	Guggenheim	Jason Cassorla	PT Raise	Buy	$242→$283
Jul 27, 2026	UBS	A.J. Rice	PT Raise	Buy	$288→$308
Jul 27, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$233→$263
Jul 27, 2026	Morgan Stanley	Craig Hettenbach	PT Raise	Overweight	$254→$274
Jul 27, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$236→$283
Jul 24, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$240→$271
Jul 20, 2026	Guggenheim	Jason Cassorla	PT Cut	Buy	$252→$242
Jul 13, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$213→$231

Analyst Ratings News

PRO
Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $290 to $305.

Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $270 to $300.

Benzinga Newsdesk

PRO
Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $309 to $342.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $283 to $304.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $281 to $321.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $307 to $306.

Benzinga Newsdesk

Tenet Healthcare Corp

Tenet Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PRO
Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PRO
Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRO
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

PRO
Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306

People Also Watch

People Also Watch

Tenet Healthcare Corp

Tenet Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PROKeybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PROLeerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRORBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PROWells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

PROGuggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306

People Also Watch

People Also Watch

PRO
Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PRO
Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PRO
Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRO
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

PRO
Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306